Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial

dc.contributor.author	Calvo Martínez, Lourdes
dc.date.accessioned	2017-06-07T07:06:30Z
dc.date.available	2017-06-07T07:06:30Z
dc.date.issued	2011
dc.identifier.issn	0008-5472
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2682
dc.language.iso	eng
dc.title	Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial
dc.type	Publicación de congreso
dc.authorsophos	Alba, E.
dc.authorsophos	Albanell, J.
dc.authorsophos	De La Haba, J.
dc.authorsophos	Barnadas, A.
dc.authorsophos	Calvo, L.
dc.authorsophos	Sanchez, P.
dc.authorsophos	Ramos, M.
dc.authorsophos	Rojo, F.
dc.authorsophos	Burgues, O.
dc.authorsophos	Porras, I.
dc.authorsophos	Tibau, A.
dc.authorsophos	Carrasco, E.
dc.authorsophos	Camara, M. C.
dc.authorsophos	Lluch, A.
dc.identifier.doi	10.1158/0008-5472.SABCS11-PD07-04
dc.identifier.sophos	8940
dc.issue.number	24 suppl
dc.journal.title	CANCER RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	71

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.